{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"melorheostosis","columns":[{"gene":"","key":"population-a0b67eba20a353bc3434","label":"Melorheostosis, isolated","mondoId":"MONDO:0007970","onsetQualifier":null,"originColumnKey":"MONDO:0007970/OMIM:155950","originalViews":[{"key":"MONDO:0007970/OMIM:155950","label":"Melorheostosis, isolated","scopeLabel":"OMIM:155950","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["35fd258cb3aff52d207b69cca3f8c3c80fc938363e75ca00a15505e6ba81a39b","44e409b28c99354cd6fb113668d5db4cfef13c48e8e31999edf44587f6c91cc1","dc6fd2ab21fc07cdd8a4523cad280ac1ccb1fc882f162f209e30cd4e8e1eaef5"],"recordQualifiers":{},"scopeLabel":"OMIM:155950","sourceIds":["OMIM:155950"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-7e32d0873985c94781d8","label":"Melorheostosis","mondoId":"MONDO:0007970","onsetQualifier":null,"originColumnKey":"MONDO:0007970/ORPHA:2485","originalViews":[{"key":"MONDO:0007970/ORPHA:2485","label":"Melorheostosis","scopeLabel":"ORPHA:2485","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["22ce9f617e804719750db66abab6682403150ff6826029e45cdf39865f5c7575","291d4edc3033382d5e80bacece54b49d97fbda6f3e3fdf8e032f5e96b42d17f4","2f709ca1d4b289513cc7601ecae259bc9d58d0d84089f963f2e10fc44a426449","392809ff30d6327008b48728be574662c332a61767aeee1b1f9e33d8f177ba25","5121377d759b60e83bb13e39f23f1ee2438a9b2bd95d3034504abb78e3aaa5d2","88a95dc403cb39b144c7fe23d4f1e7fa4c656fa8670ec9f42140bcc6934f6b16","8b5f7ecb5724e5399adc56b49a8ea4522b23bdaa27c56d1082ae8595f826b156","a71179524e721b0b74eb559059a1046cfcd4c6d211f8f85cc24a90193fe2ba29","adf9df95eb1694ad893b0df61e1255a348578ccb880020b48bab285da5d019b4","b567d4571e9a843e0e5f1d65765937e0bd5cc944af7998cbb8320f5ceabcfe5b","bcc04fabe49eec4d34a5d215b48951bd2b8e572a70eb10fb7b7990df41a0f588","c5801a029d208fa0bbc8522a3efa454c30eb9d67720bd00b82ba30320dfade86","ce4e09eb74e55173ec5c54611bbd797a0fe05f3e1ad489bf0ed53a886b2997fb","d7112e8d859cfe46b4680c0e83167780fc650909c7086deda0f4bea2a6132bac","d89b9d928d2e82d8060762484e71fd949ddb02a42bd461995f307adb4fcfc4ed","e4c3b3ee24524f1af05a5469281021787684af86c9f2751355796cb579e6f929","ea9e32eb76309a3ec0b3e4b7abac029f060455eacf9f50ea3dda32ff196de872"],"recordQualifiers":{},"scopeLabel":"ORPHA:2485","sourceIds":["ORPHA:2485"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a0b67eba20a353bc3434","population-7e32d0873985c94781d8"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000924","HP:0002829","HP:0001369","HP:0000987","HP:0002653","HP:0006824","HP:0011987"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"omim":3,"orphanet":17}},"features":[{"hpoId":"HP:0000924","label":"Abnormality of the skeletal system","primary":true},{"hpoId":"HP:0002829","label":"Arthralgia","primary":true},{"hpoId":"HP:0001369","label":"Arthritis","primary":true},{"hpoId":"HP:0000987","label":"Atypical scarring of skin","primary":true},{"hpoId":"HP:0002653","label":"Bone pain","primary":true},{"hpoId":"HP:0006824","label":"Cranial nerve paralysis","primary":true},{"hpoId":"HP:0011987","label":"Ectopic ossification in muscle tissue","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0100774","label":"Hyperostosis","primary":false},{"hpoId":"HP:0011001","label":"Increased bone mineral density","primary":false},{"hpoId":"HP:0001387","label":"Joint stiffness","primary":false},{"hpoId":"HP:0100559","label":"Lower limb asymmetry","primary":false},{"hpoId":"HP:0001004","label":"Lymphedema","primary":false},{"hpoId":"HP:6000817","label":"Melorheostosis","primary":false},{"hpoId":"HP:0100784","label":"Peripheral arteriovenous fistula","primary":false},{"hpoId":"HP:0002652","label":"Skeletal dysplasia","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false},{"hpoId":"HP:0100560","label":"Upper limb asymmetry","primary":false}],"ledeHtml":"Melorheostosis is a rare bone disease. It causes the abnormal growth of new bone tissue on the surface of existing bones. The new bone has a characteristic appearance on x-rays, often described as &quot;flowing&quot; or like dripping candle wax. The excess bone growth typically occurs on the bones in one arm or leg, although it can also affect the pelvis, breastbone (sternum), ribs, or other bones. (The term &quot;melorheostosis&quot; is derived from the Greek words &quot;melos,&quot; which means limb; &quot;rheos,&quot; which means flow; and &quot;ostosis,&quot; which refers to bone formation.) The abnormal bone growth associated with melorheostosis is noncancerous (benign), and it does not spread from one bone to another.","mondoId":"MONDO:0007970","node":{"canonicalSlug":"melorheostosis","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":["Mutations in the MAP2K1 gene are estimated to cause about half of all cases of melorheostosis. The MAP2K1 gene provides instructions for making a protein called MEK1 protein kinase. This protein is active in many kinds of cells, including bone cells. It is part of a signaling pathway called RAS/MAPK. This signaling pathway helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), and cell movement (migration). RAS/MAPK signaling is critical for normal development, including the formation of bones.","The MAP2K1 gene mutations that cause melorheostosis are somatic, which means that they occur during a person's lifetime and are present only in certain cells, in this case, bone cells in a particular area of the body. The mutations lead to the production of a version of MEK1 protein kinase that is overactive, which increases RAS/MAPK signaling in bone tissue. The increased signaling disrupts the regulation of bone cell proliferation, allowing new bone to grow abnormally. Studies suggest that increased RAS/MAPK signaling also stimulates excess bone remodeling, a normal process in which old bone is broken down and new bone is created to replace it. These changes in bone growth and turnover underlie the bone abnormalities characteristic of melorheostosis.","In cases of melorheostosis without an identified mutation in the MAP2K1 gene, the cause of the condition is usually unknown. Studies suggest that somatic mutations in other genes, particularly genes related to the RAS/MAPK signaling pathway, may also cause the disorder."],"causesUrl":"https://medlineplus.gov/genetics/condition/melorheostosis/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Melorheostosis","paragraphs":["Melorheostosis is a rare bone disease. It causes the abnormal growth of new bone tissue on the surface of existing bones. The new bone has a characteristic appearance on x-rays, often described as \"flowing\" or like dripping candle wax. The excess bone growth typically occurs on the bones in one arm or leg, although it can also affect the pelvis, breastbone (sternum), ribs, or other bones. (The term \"melorheostosis\" is derived from the Greek words \"melos,\" which means limb; \"rheos,\" which means flow; and \"ostosis,\" which refers to bone formation.) The abnormal bone growth associated with melorheostosis is noncancerous (benign), and it does not spread from one bone to another.","The signs and symptoms of melorheostosis usually appear in childhood or adolescence. The condition can cause long-lasting (chronic) pain, permanent joint deformities (contractures), and a limited range of motion of the affected body part. In some people, the limb may appear thickened or enlarged, and the skin overlying the affected area can become red, thick, and shiny.","Another rare disease, Buschke-Ollendorff syndrome, can include melorheostosis. Buschke-Ollendorff syndrome is characterized by skin growths called connective tissue nevi and areas of increased bone density called osteopoikilosis. A small percentage of affected individuals also have melorheostosis or other bone abnormalities. Scientists originally speculated that melorheostosis that occurs without the other features of Buschke-Ollendorff syndrome might have the same genetic cause as that syndrome. However, it has since been determined that Buschke-Ollendorff syndrome and melorheostosis that occurs alone are caused by mutations in different genes, and the two conditions are considered separate disorders."],"reviewed":"2018-05","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/melorheostosis"},"ownColumnKeys":["population-a0b67eba20a353bc3434","population-7e32d0873985c94781d8"],"publication":"published","relationships":[{"kind":"parent","label":"osteopetrosis","mondoId":"MONDO:0017198","slug":"osteopetrosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/9474","pageMondoId":"MONDO:0007970","source":"GARD","name":"Melorheostosis","url":"https://rarediseases.info.nih.gov/diseases/9474","relationToPage":"same-condition","coveredMondoIds":["MONDO:0007970"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:40:34Z","upstream":"GARD:0009474","rawAttribution":"MONDO:0007970","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"range","key":"22ce9f617e804719750db66abab6682403150ff6826029e45cdf39865f5c7575","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100774","is_excluded":false,"label":"Hyperostosis","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"291d4edc3033382d5e80bacece54b49d97fbda6f3e3fdf8e032f5e96b42d17f4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000987","is_excluded":false,"label":"Atypical scarring of skin","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f709ca1d4b289513cc7601ecae259bc9d58d0d84089f963f2e10fc44a426449","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001369","is_excluded":false,"label":"Arthritis","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"35fd258cb3aff52d207b69cca3f8c3c80fc938363e75ca00a15505e6ba81a39b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:155950","disease_name":"Melorheostosis, isolated","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0011001","is_excluded":false,"label":"Increased bone mineral density","onset_id":null,"reference":"OMIM:155950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"392809ff30d6327008b48728be574662c332a61767aeee1b1f9e33d8f177ba25","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002829","is_excluded":false,"label":"Arthralgia","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"44e409b28c99354cd6fb113668d5db4cfef13c48e8e31999edf44587f6c91cc1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:155950","disease_name":"Melorheostosis, isolated","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:6000817","is_excluded":false,"label":"Melorheostosis","onset_id":null,"reference":"OMIM:155950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5121377d759b60e83bb13e39f23f1ee2438a9b2bd95d3034504abb78e3aaa5d2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011001","is_excluded":false,"label":"Increased bone mineral density","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88a95dc403cb39b144c7fe23d4f1e7fa4c656fa8670ec9f42140bcc6934f6b16","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b5f7ecb5724e5399adc56b49a8ea4522b23bdaa27c56d1082ae8595f826b156","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a71179524e721b0b74eb559059a1046cfcd4c6d211f8f85cc24a90193fe2ba29","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006824","is_excluded":false,"label":"Cranial nerve paralysis","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"adf9df95eb1694ad893b0df61e1255a348578ccb880020b48bab285da5d019b4","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100784","is_excluded":false,"label":"Peripheral arteriovenous fistula","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b567d4571e9a843e0e5f1d65765937e0bd5cc944af7998cbb8320f5ceabcfe5b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bcc04fabe49eec4d34a5d215b48951bd2b8e572a70eb10fb7b7990df41a0f588","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000924","is_excluded":false,"label":"Abnormality of the skeletal system","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c5801a029d208fa0bbc8522a3efa454c30eb9d67720bd00b82ba30320dfade86","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001387","is_excluded":false,"label":"Joint stiffness","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ce4e09eb74e55173ec5c54611bbd797a0fe05f3e1ad489bf0ed53a886b2997fb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100559","is_excluded":false,"label":"Lower limb asymmetry","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d7112e8d859cfe46b4680c0e83167780fc650909c7086deda0f4bea2a6132bac","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100560","is_excluded":false,"label":"Upper limb asymmetry","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d89b9d928d2e82d8060762484e71fd949ddb02a42bd461995f307adb4fcfc4ed","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002652","is_excluded":false,"label":"Skeletal dysplasia","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"dc6fd2ab21fc07cdd8a4523cad280ac1ccb1fc882f162f209e30cd4e8e1eaef5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:155950","disease_name":"Melorheostosis, isolated","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0100774","is_excluded":false,"label":"Hyperostosis","onset_id":null,"reference":"OMIM:155950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e4c3b3ee24524f1af05a5469281021787684af86c9f2751355796cb579e6f929","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001004","is_excluded":false,"label":"Lymphedema","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ea9e32eb76309a3ec0b3e4b7abac029f060455eacf9f50ea3dda32ff196de872","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2485","disease_name":"Melorheostosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011987","is_excluded":false,"label":"Ectopic ossification in muscle tissue","onset_id":null,"reference":"ORPHA:2485","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/melorheostosis\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9474\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007970\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Melorheostosis is a rare bone disease. It causes the abnormal growth of new bone tissue on the surface of existing bones. The new bone has a characteristic appearance on x-rays, often described as &quot;flowing&quot; or like dripping candle wax. The excess bone growth typically occurs on the bones in one arm or leg, although it can also affect the pelvis, breastbone (sternum), ribs, or other bones. (The term &quot;melorheostosis&quot; is derived from the Greek words &quot;melos,&quot; which means limb; &quot;rheos,&quot; which means flow; and &quot;ostosis,&quot; which refers to bone formation.) The abnormal bone growth associated with melorheostosis is noncancerous (benign), and it does not spread from one bone to another.</p><p>The signs and symptoms of melorheostosis usually appear in childhood or adolescence. The condition can cause long-lasting (chronic) pain, permanent joint deformities (contractures), and a limited range of motion of the affected body part. In some people, the limb may appear thickened or enlarged, and the skin overlying the affected area can become red, thick, and shiny.</p><p>Another rare disease, Buschke-Ollendorff syndrome, can include melorheostosis. Buschke-Ollendorff syndrome is characterized by skin growths called connective tissue nevi and areas of increased bone density called osteopoikilosis. A small percentage of affected individuals also have melorheostosis or other bone abnormalities. Scientists originally speculated that melorheostosis that occurs without the other features of Buschke-Ollendorff syndrome might have the same genetic cause as that syndrome. However, it has since been determined that Buschke-Ollendorff syndrome and melorheostosis that occurs alone are caused by mutations in different genes, and the two conditions are considered separate disorders.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/melorheostosis\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Mutations in the MAP2K1 gene are estimated to cause about half of all cases of melorheostosis. The MAP2K1 gene provides instructions for making a protein called MEK1 protein kinase. This protein is active in many kinds of cells, including bone cells. It is part of a signaling pathway called RAS/MAPK. This signaling pathway helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), and cell movement (migration). RAS/MAPK signaling is critical for normal development, including the formation of bones.</p><p>The MAP2K1 gene mutations that cause melorheostosis are somatic, which means that they occur during a person&#x27;s lifetime and are present only in certain cells, in this case, bone cells in a particular area of the body. The mutations lead to the production of a version of MEK1 protein kinase that is overactive, which increases RAS/MAPK signaling in bone tissue. The increased signaling disrupts the regulation of bone cell proliferation, allowing new bone to grow abnormally. Studies suggest that increased RAS/MAPK signaling also stimulates excess bone remodeling, a normal process in which old bone is broken down and new bone is created to replace it. These changes in bone growth and turnover underlie the bone abnormalities characteristic of melorheostosis.</p><p>In cases of melorheostosis without an identified mutation in the MAP2K1 gene, the cause of the condition is usually unknown. Studies suggest that somatic mutations in other genes, particularly genes related to the RAS/MAPK signaling pathway, may also cause the disorder.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/melorheostosis/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"melorheostosis","sourceDocuments":[{"name":"MedlinePlus: Melorheostosis","reviewed":"2018-05","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/melorheostosis"},{"name":"GARD: Melorheostosis","reviewed":null,"source_release":"2026-10-25T03:40:34Z","url":"https://rarediseases.info.nih.gov/diseases/9474"},{"name":"MONDO: melorheostosis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007970"}],"sourceNote":"","synonyms":["melorheostosis, isolated, somatic mosaic"],"takeawayHtml":"","title":"melorheostosis"},"schemaVersion":1}
